Aspen Aerogels, Inc. Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Continued cost discipline delivered 42% company gross margins and 22% Adjusted EBITDA margins
Increased 2024 Financial Outlook to
Various financing activities completed to fully-fund growth strategy
Total revenue for the third quarter of 2024 was
Adjusted EBITDA for the third quarter of 2024 was
Recent Business Highlights & Quarterly Performance
- Company revenue of
$117.3 million , up 93% year-over-year (YoY)- Thermal Barrier: $90.6 million of revenue, up 176% YoY
Energy Industrial : $26.8 million of supply constrained revenue, down 4% YoY
- Completed 5-week turnaround of external manufacturing facility to enable expanded supply capacity for
Energy Industrial segment - Delivered gross margins of 42%, a 19-percentage point improvement YoY
- Net loss of
$13.0 million , which included a$27.5 million one-time charge from the redemption of the Company's convertible note, a$0.1 million improvement YoY. Adjusting net income for the above one-time charge would result in net income of$14.5 million , a$27.4 million YoY improvement - Adjusted EBITDA of
$25.4 million (22% margin), a$32.6 million improvement YoY - Operating income of
$17.4 million , a$32.0 million improvement YoY - Cash generated from operations of
$20.8 million in the quarter - Ended third quarter of 2024 with cash and equivalents of
$113.5 million
Recent Financing Activity
- On
August 19, 2024 , closed on$125 million term loan facility and drew$43 million of$100 million capacity asset-based revolving credit facility with MidCap Financial, a leading commercial finance company managed byApollo Capital Management, L.P. - The proceeds from the above transaction were utilized for the full cash redemption of the Company's legacy convertible note of
$150.0 million - On
October 16, 2024 , the Company announced that it had received conditional commitment from theU.S. Department of Energy Loan Programs Office for a proposed loan of up to$670.6 million for financing the construction of its planned second aerogel manufacturing facility ("Statesboro Plant") inStatesboro, Georgia – full press release link - On
October 21, 2024 , closed underwritten public offering with net proceeds of approximately$93.2 million for funding growth CAPEX and to enable opportunistic near-term investment
"We are fully capitalized to execute our current strategy and are well-positioned for continued profitable growth," noted
Updated 2024 Financial Outlook
($ in millions, except per share amounts) |
|
|
|
|||||
Metric |
February (2/12/2024) |
May Update (5/1/2024) |
August Update (8/7/2024) |
Current |
Δ Over August |
|||
Revenue |
>350 |
>380 |
>390 |
450 |
60 |
|||
YoY Growth |
47 % |
59 % |
63 % |
88 % |
||||
Net Income (Loss)* |
>(23) |
>2 |
>7 |
9* |
2 |
|||
Adjusted EBITDA |
>30 |
>55 |
>60 |
90 |
30 |
|||
Earnings Per Share |
>(0.30) |
>0.03 |
>0.09 |
0.11* |
0.02 |
*Current 2024 Outlook now includes a
The Company's 2024 outlook assumes depreciation and amortization of
A reconciliation of net income to Adjusted EBITDA for the 2024 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."
Last Twelve-Month Financial Comparison
A comparison of key financial metrics for the trailing twelve-month periods ended
($ in millions, numbers may not total due to rounding) |
||||||
Metric |
|
LTM Q3 2023 |
LTM Q3 2024 |
Delta |
% Improvement |
|
Revenue |
|
214 |
414 |
200 |
93 % |
|
Gross Profit |
|
42 |
165 |
124 |
297 % |
|
|
% Margin |
19 % |
40 % |
|
||
Net Income (Loss) |
|
(55) |
1 |
56 |
103 % |
|
|
% Margin |
(26 %) |
0 % |
|
||
Adjusted EBITDA |
|
(37) |
76 |
113 |
309 % |
|
|
% Margin |
(17 %) |
18 % |
|
||
Operating Income |
|
(60) |
41 |
101 |
168 % |
|
|
% Margin |
(28 %) |
10 % |
|
||
Total CAPEX |
|
206 |
99 |
(107) |
52 % |
|
Conference Call and Webcast Notification
A conference call with
Shareholders and other interested parties may call +1 (833) 470-1428 (domestic) or +1 (929) 526-1599 (international) and reference conference ID "921873" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted at the Investors section of
Following the live event, an archived version of the webcast will be available on
Non-GAAP Financial Measures
In addition to providing financial measurements based on generally accepted accounting principles in
Management believes that this non-GAAP financial measure reflects
The non-GAAP financial measure does not replace the presentation of
About
Special Note Regarding Forward-Looking and Cautionary Statements
This press release and any related discussion contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to
ASPEN AEROGELS, INC. Condensed Consolidated Balance Sheets (Unaudited and in thousands) |
||||||||
|
||||||||
|
|
|
|
|
|
|
||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In thousands) |
|
|||||
Assets |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
113,489 |
|
|
$ |
139,723 |
|
Restricted cash |
|
|
394 |
|
|
|
248 |
|
Accounts receivable, net |
|
|
115,199 |
|
|
|
69,995 |
|
Inventories |
|
|
47,430 |
|
|
|
39,189 |
|
Prepaid expenses and other current assets |
|
|
29,344 |
|
|
|
17,176 |
|
Total current assets |
|
|
305,856 |
|
|
|
266,331 |
|
Property, plant and equipment, net |
|
|
451,569 |
|
|
|
417,227 |
|
Operating lease right-of-use assets |
|
|
20,373 |
|
|
|
17,212 |
|
Other long-term assets |
|
|
4,789 |
|
|
|
2,278 |
|
Total assets |
|
$ |
782,587 |
|
|
$ |
703,048 |
|
Liabilities and Stockholders' Equity |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
42,280 |
|
|
$ |
51,094 |
|
Accrued expenses |
|
|
26,531 |
|
|
|
22,811 |
|
Deferred revenue |
|
|
2,405 |
|
|
|
2,316 |
|
Finance obligation for sale and leaseback transactions |
|
|
3,653 |
|
|
|
— |
|
Operating lease liabilities |
|
|
3,181 |
|
|
|
1,874 |
|
Long term debt - current portion |
|
|
26,250 |
|
|
|
— |
|
Total current liabilities |
|
|
104,300 |
|
|
|
78,095 |
|
Revolving line of credit |
|
|
42,735 |
|
|
|
— |
|
Long term debt |
|
|
93,674 |
|
|
|
— |
|
Convertible note - related party |
|
|
— |
|
|
|
114,992 |
|
Finance obligation for sale and leaseback transactions long-term |
|
|
10,486 |
|
|
|
— |
|
Operating lease liabilities long-term |
|
|
23,742 |
|
|
|
21,906 |
|
Total liabilities |
|
|
274,937 |
|
|
|
214,993 |
|
Stockholders' equity: |
|
|
|
|
|
|
||
Total stockholders' equity |
|
|
507,650 |
|
|
|
488,055 |
|
Total liabilities and stockholders' equity |
|
$ |
782,587 |
|
|
$ |
703,048 |
|
Consolidated Statements of Operations (Unaudited and in thousands, except share and per share data) |
||||||||||||||||
|
||||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
|
|
(In thousands, except |
|
|||||||||||||
Revenue |
|
$ |
117,340 |
|
|
$ |
60,755 |
|
|
$ |
329,611 |
|
|
$ |
154,499 |
|
Cost of revenue |
|
|
68,297 |
|
|
|
46,945 |
|
|
|
193,847 |
|
|
|
127,196 |
|
Gross profit |
|
|
49,043 |
|
|
|
13,810 |
|
|
|
135,764 |
|
|
|
27,303 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Research and development |
|
|
4,591 |
|
|
|
4,218 |
|
|
|
13,645 |
|
|
|
12,281 |
|
Sales and marketing |
|
|
9,306 |
|
|
|
8,386 |
|
|
|
27,130 |
|
|
|
24,226 |
|
General and administrative |
|
|
17,746 |
|
|
|
15,840 |
|
|
|
52,465 |
|
|
|
41,382 |
|
Impairment of equipment under development |
|
|
— |
|
|
|
— |
|
|
|
2,702 |
|
|
|
— |
|
Total operating expenses |
|
|
31,643 |
|
|
|
28,444 |
|
|
|
95,942 |
|
|
|
77,889 |
|
Income (loss) from operations |
|
|
17,400 |
|
|
|
(14,634) |
|
|
|
39,822 |
|
|
|
(50,586) |
|
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Interest expense, convertible note - related party |
|
|
(1,469) |
|
|
|
(1,938) |
|
|
|
(7,550) |
|
|
|
(2,424) |
|
Interest income (expense) |
|
|
(1,147) |
|
|
|
1,313 |
|
|
|
(883) |
|
|
|
5,532 |
|
Income from Employee Retention Credits |
|
|
— |
|
|
|
2,186 |
|
|
|
— |
|
|
|
2,186 |
|
Loss on extinguishment of debt |
|
|
(27,487) |
|
|
|
— |
|
|
|
(27,487) |
|
|
|
— |
|
Total other income (expense) |
|
|
(30,103) |
|
|
|
1,561 |
|
|
|
(35,920) |
|
|
|
5,294 |
|
Income (loss) before income tax expense |
|
|
(12,703) |
|
|
|
(13,073) |
|
|
|
3,902 |
|
|
|
(45,292) |
|
Income tax expense |
|
|
(267) |
|
|
|
— |
|
|
|
(1,889) |
|
|
|
— |
|
Net income (loss) |
|
$ |
(12,970) |
|
|
$ |
(13,073) |
|
|
$ |
2,013 |
|
|
$ |
(45,292) |
|
Net income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
$ |
(0.17) |
|
|
$ |
(0.19) |
|
|
$ |
0.03 |
|
|
$ |
(0.65) |
|
Diluted |
|
$ |
(0.17) |
|
|
$ |
(0.19) |
|
|
$ |
0.03 |
|
|
$ |
(0.65) |
|
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
|
76,261,294 |
|
|
|
69,317,805 |
|
|
|
76,402,123 |
|
|
|
69,243,843 |
|
Diluted |
|
|
76,261,294 |
|
|
|
69,317,805 |
|
|
|
79,149,193 |
|
|
|
69,243,843 |
|
Analysis of Cash Flow
The following table summarizes our cash flows for the periods indicated.
|
|
Three Months Ended |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
(In thousands) |
|
|
|
|
|
||
Net cash provided by (used in): |
|
|
|
|
|
|
|
|
|
|||
Operating activities |
|
$ |
(17,749) |
|
|
$ |
6,843 |
|
|
$ |
20,771 |
|
Investing activities |
|
|
(25,863) |
|
|
|
(24,827) |
|
|
|
(20,821) |
|
Financing activities |
|
|
5,259 |
|
|
|
8,141 |
|
|
|
22,158 |
|
Net (decrease) increase in cash |
|
|
(38,353) |
|
|
|
(9,843) |
|
|
|
22,108 |
|
Cash, cash equivalents and restricted cash at beginning of period |
|
|
139,971 |
|
|
|
101,618 |
|
|
|
91,775 |
|
Cash, cash equivalents and restricted cash at end of period |
|
$ |
101,618 |
|
|
$ |
91,775 |
|
|
$ |
113,883 |
|
Reconciliation of Non-GAAP Financial Measures
The following tables present a reconciliation of the non-GAAP financial measure included in this press release to the most directly comparable GAAP measure:
Reconciliation of Adjusted EBITDA to Net loss
We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance.
For the three and nine months ended
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
|
|
(In thousands) |
|
|||||||||||||
Net income (loss) |
|
$ |
(12,970) |
|
|
$ |
(13,073) |
|
|
$ |
2,013 |
|
|
$ |
(45,292) |
|
Depreciation and amortization |
|
|
5,321 |
|
|
|
4,550 |
|
|
|
17,093 |
|
|
|
10,757 |
|
Stock-based compensation |
|
|
2,630 |
|
|
|
2,789 |
|
|
|
10,307 |
|
|
|
7,766 |
|
Other expense (income) |
|
|
2,616 |
|
|
|
(1,561) |
|
|
|
8,433 |
|
|
|
(5,294) |
|
Loss on extinguishment of debt |
|
|
27,487 |
|
|
|
- |
|
|
|
27,487 |
|
|
|
- |
|
Income tax expense |
|
|
267 |
|
|
|
- |
|
|
|
1,889 |
|
|
|
- |
|
Adjusted EBITDA |
|
$ |
25,351 |
|
|
$ |
(7,295) |
|
|
$ |
67,222 |
|
|
$ |
(32,063) |
|
For the trailing twelve months ended
|
|
Last Twelve Months |
|
|||||
|
|
|
|
|||||
|
|
2024 |
|
|
2023 |
|
||
|
|
(In thousands) |
|
|||||
Net income (loss) |
|
$ |
1,494 |
|
|
$ |
(54,901) |
|
Depreciation and amortization |
|
|
21,654 |
|
|
|
13,287 |
|
Stock-based compensation |
|
|
13,495 |
|
|
|
10,438 |
|
Other expense (income) |
|
|
10,335 |
|
|
|
(5,351) |
|
Loss on extinguishment of debt |
|
|
27,487 |
|
|
|
- |
|
Income tax expense |
|
|
1,889 |
|
|
|
- |
|
Adjusted EBITDA |
|
$ |
76,354 |
|
|
$ |
(36,527) |
|
For the 2024 full year financial outlook:
|
|
Year Ending |
|
|||||||||||||
|
|
|
|
|||||||||||||
|
|
Current |
|
|
August Update |
|
|
May Update |
|
|
February |
|
||||
|
|
(In thousands) |
|
|||||||||||||
Net income (loss) |
|
$ |
9,000 |
|
|
$ |
7,000 |
|
|
$ |
2,000 |
|
|
$ |
(23,000) |
|
Depreciation and amortization |
|
|
25,000 |
|
|
|
30,000 |
|
|
|
30,000 |
|
|
|
30,000 |
|
Stock-based compensation |
|
|
14,000 |
|
|
|
14,000 |
|
|
|
14,000 |
|
|
|
14,000 |
|
Other expense, net and income tax expense |
|
|
14,500 |
|
|
|
9,000 |
|
|
|
9,000 |
|
|
|
9,000 |
|
Loss on extinguishment of debt |
|
|
27,500 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Adjusted EBITDA |
|
$ |
90,000 |
|
|
$ |
60,000 |
|
|
$ |
55,000 |
|
|
$ |
30,000 |
|
View original content:https://www.prnewswire.com/news-releases/aspen-aerogels-inc-reports-third-quarter-2024-financial-results-and-recent-business-highlights-302298009.html
SOURCE